Antiendotoxin activity of cationic peptide antimicrobial agents.
about
Evolutionary relationships among virulence-associated histidine kinasesImpact of acute stress on antimicrobial polypeptides mRNA copy number in several tissues of marine sea bass (Dicentrarchus labrax)Defense peptides secreted by helminth pathogens: antimicrobial and/or immunomodulator molecules?De novo design and synthesis of ultra-short peptidomimetic antibiotics having dual antimicrobial and anti-inflammatory activities.Calcium adsorption and displacement: characterization of lipid monolayers and their interaction with membrane-active peptides/proteins.Covalent polymyxin B conjugate with human immunoglobulin G as an antiendotoxin reagent.Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications.Binding interactions of bacterial lipopolysaccharide and the cationic amphiphilic peptides polymyxin B and WLBU2.Activities of synthetic hybrid peptides against anaerobic bacteria: aspects of methodology and stabilityThe role of antimicrobial peptides in animal defenses.Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptideSingle-dose intraperitoneal magainins improve survival in a gram-negative-pathogen septic shock rat modelPotential therapeutic role of cationic peptides in three experimental models of septic shock.Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.Effect of vitamin D supplementation on Mycobacterium tuberculosis-induced innate immune responses in a Canadian Dené First Nations cohortLL-37 protects rats against lethal sepsis caused by gram-negative bacteriaThe use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.Successful use of intravitreal and systemic colistin in treating multidrug resistant Pseudomonas aeruginosa post-operative endophthalmitisThe role of antimicrobial peptides in preventing multidrug-resistant bacterial infections and biofilm formation.A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media.Consequences of alteration in leucine zipper sequence of melittin in its neutralization of lipopolysaccharide-induced proinflammatory response in macrophage cells and interaction with lipopolysaccharide.Bound to shock: protection from lethal endotoxemic shock by a novel, nontoxic, alkylpolyamine lipopolysaccharide sequestrant.Antibacterial effects of Lactobacillus and bacteriocin PLNC8 αβ on the periodontal pathogen Porphyromonas gingivalis.Synthetic mimics of antimicrobial peptides with immunomodulatory responsesToll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells.Genome wide analysis of the antimicrobial peptides in Python bivittatus and characterization of cathelicidins with potent antimicrobial activity and low cytotoxicity.Peptide antimicrobial agents.Identification of cell-penetrating peptides that are bactericidal to Neisseria meningitidis and prevent inflammatory responses upon infectionHost defense peptides in wound healing.A Novel RNase 3/ECP Peptide for Pseudomonas aeruginosa Biofilm Eradication That Combines Antimicrobial, Lipopolysaccharide Binding, and Cell-Agglutinating Activities.De novo design of potent antimicrobial peptidesIntracellular Targeting Mechanisms by Antimicrobial PeptidesThe C-terminal Domain Supports a Novel Function for CETPI as a New Plasma Lipopolysaccharide-Binding ProteinIn vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa.Salt-resistant alpha-helical cationic antimicrobial peptides.Polymyxin B-Resistant Acinetobacter baumannii Clinical Isolate Susceptible to Recombinant BPI and Cecropin P1.Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis.Interaction of NK lysin, a peptide produced by cytolytic lymphocytes, with endotoxin.Biological properties of structurally related alpha-helical cationic antimicrobial peptides.
P2860
Q28492956-99DF06AA-2243-4D34-A8D7-3B5EC4628503Q28732218-46310BA5-3C4C-4F65-BFDC-BC436BEAE056Q30564789-7E7F97B7-CC65-43FA-9FA0-D005F30C55A5Q31145703-199FACAE-3468-4B62-91FA-FC4D28C481C3Q33242093-AA50C8BD-801C-42B0-AE5A-870159DAC10BQ33691053-1B21777F-F682-4404-A2B2-96B47D81E1E0Q33938255-61694BE6-B8B3-4C1A-9618-2CC58762F6E6Q33959844-E9580E27-1B51-40C8-AD6D-5246CF4B4C7EQ33978441-C04E5C11-0DC2-4362-A9A4-FCF4AA3A7EF8Q33988529-206C1CBA-85C6-44B9-AC71-CBE2E6D5D511Q34000667-F916D159-2F8C-4800-82BE-039530D8E237Q34104726-1E0C475D-8BB8-407D-BC6A-7EF7283891E3Q34109677-6583860D-FC2F-4FD5-9A18-083D11BC2A9FQ34113672-66BE1766-509A-455F-8C0F-E5E665766B19Q34367177-EC3FCCA7-A6A2-4A6C-ADC0-0FDDE86F37B4Q34648782-E514360C-8101-429D-A63D-43352A6CF6A9Q34652418-E8354124-760A-4949-B6CE-2B51069B715EQ34721515-6AD89CFA-3C3B-4E2F-90DE-587FA4222616Q35036879-4D5D5F44-CCB2-4FB5-A78D-AD6D8AB7A6DDQ35297286-ECCD0B8C-1119-4FA8-BFDA-BD02F43F09DCQ35672138-E46A7AFD-7DA1-4754-961D-03B2C60FA650Q35694011-F000D229-5B53-49D9-BBC7-5746C85DA8CAQ35912677-5C5151C7-EA57-4EF2-99EA-FB142EE8CBE6Q36107381-B652A343-23DB-4323-841E-90013A15ABA8Q36122395-CC51BD5A-0EEB-490D-8566-6F0B70679B9EQ36370326-423D87D5-B4F4-4A4D-A597-79C7CBDBDCF7Q36409833-ABE38680-50D6-467F-91D0-3E493CBD2CDEQ36538861-F4CB9129-0082-4ECF-9997-A0B417922DAAQ37036638-EEDD14B9-FE4A-43BF-B0B2-8565FCBA8663Q37127271-EAE23AC4-169E-4A3D-98DC-93318A4EC0B4Q37287708-A7B80106-E0A3-424F-9710-2B35B7D83D9CQ37489546-7BF4D112-D650-4E93-A2E0-4460B2528793Q38760670-31549AEB-9DC1-4285-957D-F59D1A1B9D94Q38821997-1FC5071A-6F63-4A93-B467-7B3FEC156A40Q39077770-0574EEFE-E640-4074-8C32-3BB8BD35D8CBQ39471096-5E9D77A9-15C1-4719-8779-96B2F3F87CA9Q39476770-18A6E1EE-91D2-42DC-A035-8BAB4CB04213Q39478540-8F49ECBA-4055-4D0A-B1B1-D94F97A495A7Q39509227-94C7B01B-E4C0-4C0E-A033-F6CA333AD43CQ39510622-A6216437-3DA8-4EA3-BB78-B1B61506A557
P2860
Antiendotoxin activity of cationic peptide antimicrobial agents.
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Antiendotoxin activity of cationic peptide antimicrobial agents.
@ast
Antiendotoxin activity of cationic peptide antimicrobial agents.
@en
type
label
Antiendotoxin activity of cationic peptide antimicrobial agents.
@ast
Antiendotoxin activity of cationic peptide antimicrobial agents.
@en
prefLabel
Antiendotoxin activity of cationic peptide antimicrobial agents.
@ast
Antiendotoxin activity of cationic peptide antimicrobial agents.
@en
P2093
P2860
P1476
Antiendotoxin activity of cationic peptide antimicrobial agents.
@en
P2093
P2860
P304
P407
P577
1996-12-01T00:00:00Z